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Introduction
Cellular differentiation programs are tightly controlled through
the coordinated regulation of gene expression. Basic helix-loop-
helix (bHLH) transcription factors regulate the differentiation
programs of multiple cell lineages (reviewed in Norton, 2000).
These proteins share a common sequence motif of a stretch of
basic amino acids responsible for site-specific DNA binding
adjacent to a helix-loop-helix dimerization domain.The Id family
of helix-loop-helix proteins does not possess a basic DNA bind-
ing domain and functions as a dominant-negative regulator of
basic HLH proteins through the formation of inactive het-
erodimers with intact bHLH transcription factors (Figure 1). The
Id family of proteins (comprised of 4 members designated
Id1–Id4) has been demonstrated to bind the ubiquitously
expressed bHLH E-proteins or cell lineage-restricted bHLH
transcription factors, leading to inhibition of lineage-specific
gene expression and differentiation (Norton et al., 1998).
Hence, the name Id refers to both inhibition of differentiation
and inhibition of DNA binding. Transcriptional inhibition by Id
proteins is mediated via inhibition of DNA binding of bHLH or
other activator proteins at E boxes (CANNTG), N boxes (CAC-
NAG), or Ets sites (GGAA/T) present in the promoter regions of
regulated genes (reviewed in Zebedee and Hara, 2001). Since
cellular differentiation programs are frequently altered during
the development of neoplastic disease, it is not surprising that
Id proteins would play a role in this process. Indeed, a clue to
the potential role of Id genes in tumorigenesis came with the
observation that, in general, high Id expression levels are found
in proliferative, undifferentiated cells—a feature which is char-
acteristic of tumor cells (Israel et al., 1999). Over the past sever-
al years, the particular mechanisms underlying the effects of Id
genes on cell growth and differentiation have been investigated.
Here we review data supporting the critical role of Id gene regu-
lation in the development of normal cellular differentiation pro-
grams. We also review mechanisms of Id gene regulation of
cellular growth controls and the cell cycle machinery and evalu-
ate the contribution of dysregulated Id gene expression to the
process of tumorigenesis.
Id regulation of cellular differentiation
The first direct genetic evidence for a role of Id proteins in regulat-
ing cellular differentiation came from mutational studies of the
Drosophila emc locus. Drosophila emc, a helix-loop-helix protein,
functions in a manner similar to Id proteins in that it forms het-
erodimers with bHLH target proteins and prevents them from
binding DNA and functioning transcriptionally. Loss- and gain-
of-function mutants of emc in Drosophila showed that emc
inhibits the functions of Daughterless and achaete-scute bHLH
proteins, which are involved in sex determination and neuroge-
nesis (Campuzano, 2001). Later, in mammalian cell culture sys-
tems, differentiation of various cell lineages was shown to be
accompanied by downregulation of Id expression, while over-
expression of Id proteins within these systems, including ker-
atinocytes, myoblasts, myeloid precursor cells, mammary
epithelium, and preadipose cells, was shown to inhibit their abil-
ity to differentiate under appropriate conditions (reviewed in
Lasorella et al., 2001). More recently, in vivo studies using tar-
geted expression of Id genes to thymocytes (Kim et al., 1999;
Morrow et al., 1999), intestinal epithelia (Wice and Gordon,
1998), and B-lymphocytes (Sun, 1994) of mice have demon-
strated inhibition of cellular differentiation in these systems.
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Since the gene encoding Id1 was cloned in 1990, Id proteins have been implicated in regulating a variety of cellular process-
es, including cellular growth, senescence, differentiation, apoptosis, angiogenesis, and neoplastic transformation.The devel-
opment of knockout and transgenic animal models for many members of the Id gene family has been particularly useful in
sorting out the biologic relevance of these genes and their expression during normal development, malignant transformation,
and tumor progression. Here we review the current understanding of Id gene function, the biologic consequences of Id gene
expression, and the implications for Id gene regulation of cell growth and tumorigenesis.
Figure 1. Model for Id effects on bHLH transcription
A: In the absence of Id proteins, dimers of bHLH proteins can bind DNA and
activate transcription of differentiation-associated genes. 
B: With expression of Id proteins, bHLH-Id dimers form which are unable to
bind DNA and expression of differentiation-associated genes is inhibited.
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While several lineage-specific bHLH proteins involved in
endothelial, muscle, neuronal, and hematopoietic cell differenti-
ation have been identified (reviewed in Norton et al., 1998), no
putative bHLH proteins involved in epithelial cell differentiation
have been defined to date. Since previous work on Id gene func-
tion in human keratinocytes (Alani et al., 1999; Nickoloff et al.,
2000), breast (Desprez et al., 1995), and intestinal epithelia
(Wice and Gordon, 1998) suggests that lineage-specific bHLH
proteins are likely to exist in these systems, it is anticipated that
they will be identified and characterized in the near future.
Id proteins in development
Over the past few years, much work has focused on determining
the role of Id proteins during development. In situ analyses of Id
gene expression during mouse development have demonstrat-
ed widespread expression of Id1, Id2, and Id3 throughout the
developing organism from early gestation through birth with
considerable overlap in expression patterns of Id1 and Id3 and
distinct expression of Id4 limited to the nervous system (Yokota,
2001). In an attempt to define the role of Id genes in develop-
ment, several knockout animal models have been generated
(Table 1). Deletion of the Id1 gene alone failed to produce an
obvious phenotype, while mice that were null for Id2 possessed
defects in immunity due to a lack of lymph nodes and Peyer’s
patches and a severely reduced population of natural killer (NK)
cells and Langerhans cells, and mice null for Id3 possessed
defects in B cell proliferation and humoral immunity (Hacker et
al., 2003; Yokota, 2001). Given the overlapping expression pat-
terns of Id1 and Id3 during embryogenesis, it was hypothesized
that redundant functions existed between the Id1 and Id3 pro-
teins. Indeed, mice that were null for both Id1 and Id3 were sub-
sequently generated and found to possess embryonic lethality
(E13.5) with aberrant neuronal differentiation and angiogenesis
(Lyden et al., 1999). Specifically, neuroblasts were shown to
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Table 1. Putative role for Id proteins in development and tumorigenesis
Gene deleted Phenotype Reference
Id1−/− No major abnormalities, elevated TSP-1 expression (Volpert et al., 2002; Yan et al., 1997) 
Id2−/− Lack lymph nodes, NK cells and Peyer’s patches; (Hacker et al., 2003; Yokota et al., 1999)
defects in spermatogenesis; loss of Langerhans cells
Id3−/− Abnormalities in humoral immunity and T cell development (Kee et al., 2001; Pan et al., 1999; Rivera et al., 2000)
Id1 −/−, Id3 −/− Lethal E13.5, vascular defects in forebrain, (Lyden et al., 1999)
premature maturation of neurons 
Id1/Id3 Defects in vascularization and growth of tumor xenografts (Lyden et al., 1999)
loss of single or multiple alleles
Id2−/−, Rb−/− Compensatory resolution of Rb−/− defects in neurogenesis (Lasorella et al., 2000)
and hematopoiesis. Rescue of Rb−/− embryonic lethality 
but severe muscle loss leads to postnatal demise
Murine models have clarified the role of Id proteins in a variety of developmental processes and tumor growth and metastasis. Mouse models for Id genes
are listed with their associated phenotypes.
Figure 2. Model for Id gene function in cell cycle progression
Common cell cycle regulatory pathways in which Id gene regulation has been implicated are shown above. Id phosphorylation by cyclin-dependent
kinases in late G1 is shown. This modified Id protein inhibits Id-bHLH dimer formation as shown. bHLH-mediated activation of the cdk-inhibitory proteins p15,
p16, and p21 is also shown. This activity is also inhibited by Id proteins. The particular function of Id2 and its association with the retinoblastoma family of pro-
teins (pRB) is also noted. Id2 interactions with pRB allow for release of E2F, expression of S phase genes, and cell cycle progression. All Id interactions noted
support the role of Id proteins in cell cycle progression.
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withdraw from the cell cycle prematurely with enhanced
expression of neural-specific differentiation markers. In addi-
tion, these mice displayed vascular malformations in the fore-
brain and an absence of branching and sprouting of blood
vessels into the neuroectoderm. While the expression patterns
of neuronal and endothelial differentiation markers were evalu-
ated in Id1/Id3 double null embryos and found to be altered, the
specific targets of Id genes in these systems remain to be
elucidated.
Id proteins and the cell cycle
A growing body of evidence has implicated Id proteins as play-
ing a critical role in promoting G1-S cell cycle transitions. Early
insights into the role of Id proteins in cell cycle control came with
the cloning of Id3 as a mitogen-induced early response gene
and later identification of Id1, Id2, and Id3 as being mitogen-
responsive (Lasorella et al., 2001). Id genes were further impli-
cated in promoting cell cycle progression, since antisense Id
constructs introduced into serum-stimulated NIH 3T3 cells were
shown to delay cell cycle reentry in these cells, while micro-
injection of anti-Id antibodies into serum stimulated NIH 3T3
cells led to late G1 withdrawal of these cells from the cell cycle
(Lasorella et al., 2001). Id proteins have been more directly
implicated in regulating cell cycle control, as the particular fac-
tors involved in these pathways have been elucidated. Id2 and
Id3 have been shown to be phosphorylated in late G1 by cyclin-
dependent kinase 2 (cdk2) (Deed et al., 1997; Hara et al.,
1997), and Id2 has been found to reverse cellular growth inhibi-
tion by the retinoblastoma protein (pRb) through direct
interaction with pRb, p107, and p130 via its HLH domain
(reviewed in Lasorella et al., 2001). Moreover, Id2 had been
shown to interact genetically with pRb since Id2/pRb double
knockout animals display partial suppression of Rb null-associ-
ated embryonic lethality (Lasorella et al., 2000). Id1 has also
been shown to inhibit E-protein and Ets-protein-mediated acti-
vation of the cdk inhibitor p16/INK4a (Alani et al., 2001; Ohtani
et al., 2001), and Id1 null mouse embryo fibroblasts were shown
to senesce prematurely due to increased expression of
p16/INK4a (Alani et al., 2001). Since this tumor suppressor pro-
tein functions in the same pathway as pRb, these data suggest
that Id proteins can inactivate this pathway either through direct
interaction with pRb or through altered expression of genes that
regulate Rb phosphorylation and, ultimately, function (Figure 2).
Other cell cycle regulatory proteins involved in the pRb pathway
have been shown to be affected by Id expression, and analysis
of the promoter regions of the cell cycle inhibitory proteins p15,
p16/Ink4a, and p21 (Pagliuca et al., 2000; Prabhu et al., 1997)
has demonstrated activation by E-proteins, which is abrogated
by Id proteins.
Id proteins and apoptosis
Id genes have been shown to promote apoptosis in a variety of
settings. Transgenic mice with targeted Id1 expression in T cells
showed a 96% reduction in the total number of thymocytes due
to massive apoptosis (Kim et al., 1999). In addition, Id1 expres-
sion in dense mammary epithelial cell cultures induces apopto-
sis (Parrinello et al., 2001), Id3 expression induces apoptosis in
B-lymphocytes (Kee et al., 2001), Id4 induces apoptosis in an
astrocyte-derived cell line (Andres-Barquin et al., 1999), and
Id1 induces apoptosis in neonatal and adult cardiac myocytes
through a redox-dependent mechanism (Tanaka et al., 1998).
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Table 2. Id gene expression in primary human malignancies
Tumor type Deregulated Id Reference
Breast cancer Id1* (Lin et al., 2000; 
Schoppmann et al., 2003)
Thyroid cancer Id1* (Kebebew et al., 2000)
Endometrial cancer Id1* (Takai et al., 2001)
Cervical cancer Id1* (Schindl et al., 2001)
Ovarian cancer Id1* (Schindl et al., 2003)
Squamous cell Id1* (Hu et al., 2001)
cancer (esophagus)
Squamous cell Id1* (Wang et al., 2002)
cancer (nasopharynx)
Melanoma Id1 (Polsky et al., 2001)
Prostate cancer Id1* (Ouyang et al., 2002)
Ewing sarcoma Id2 (Fukuma et al., 2003; 
Nishimori et al., 2002)
Squamous cell cancer Id1, Id2, Id3 (Langlands et al., 2000)
(head and neck) 
Colorectal Id1*, Id2, Id3 (Wilson et al., 2001)
cancer
Astrocytic tumors Id1*, Id2, Id3 (Vandeputte et al., 2002)
Pancreatic cancer Id1*, Id2, Id3 (Maruyama et al., 1999)
Testicular seminomas Id1*, Id2, Id3, Id4 (Sablitzky et al., 1998)
The above primary human tumors have been evaluated for Id gene
expression by a variety of methods. Given concerns regarding specificity
of reagents for Id1 detection in primary tumors, those tumors evaluated by
antibody detection are designated with an asterisk (*).
Figure 3. Model for Id gene regulation of tumor
angiogenesis
Id gene expression has been shown to influence
endothelial cells through the angiogenesis
inhibitor thrombospondin-1 (TSP-1) and through
VEGF receptor-mediated functions (VEGFR1,2)
on myeloid precursor cells and circulating
endothelial precursor cells (CEPs). Tumor cells
release increased levels of VEGF, which signals
bone marrow-derived cells and preexisting
endothelial cells to upregulate Id1 and/or Id3
gene expression. Id genes subsequently pro-
mote angiogenesis in tumors through the mobi-
lization and increased proliferation of bone
marrow-derived cells or through effects on pre-
existing endothelial cells, including downregu-
lated expression of the angiogenesis inhibitor
thrombospondin-1 (TSP-1).
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The significance of apoptotic functions of Id proteins with
respect to the development of human malignancies is still under
investigation, and a potential tumor-suppressive function asso-
ciated with high-level Id expression analogous to that seen with
myc oncoproteins seems likely.
Id proteins and tumorigenesis
Id genes have been identified as potential protooncogenes,
since overexpression of Id proteins in primary cells has been
demonstrated to promote cellular immortalization; however,
tumor-associated defects in Id genes have not been identified to
date. Id1, Id2, and Id3 have each been shown to extended the
lifespan of primary human keratinocytes (Alani et al., 1999;
Nickoloff et al., 2000), and endothelial cells (Tang et al., 2002),
while constitutive expression of Id1 alone has been shown to
immortalize human keratinocytes and result in activation of telo-
merase activity and inactivation of the retinoblastoma protein
(Alani et al., 1999). Id gene expression has been shown to be
elevated in various tumor cell lines by Northern and Western
analysis, including lung tumor cells, astrocytic tumor cells, colon
cancer cells, Ewing sarcoma cells, and chondrosarcoma cells
(Fukuma et al., 2003; Nishimori et al., 2002; reviewed in
Lasorella et al., 2001). In addition, breast cancer cell lines that
express Id1 have been shown to possess more invasive pheno-
types than those that did not (Desprez et al., 1998), and Id1 pro-
moter activity has been shown to be activated in metastatic
breast cancers in association with loss of a retinoblastoma/his-
tone deacetylase transcriptional repressor complex (Singh et
al., 2002). In other recent work, Id1 has been shown to be a
transcriptional target of Kaposi’s sarcoma herpesvirus-associ-
ated genes in human endothelial cells (Tang et al., 2003). We
await further clarification of the role of Id genes in the genesis of
this malignancy.
Over the past several years, Id1 gene expression has been
shown to be elevated in a variety of primary human tumors ver-
sus normal control tissue specimens, including breast cancers
(Lin et al., 2000; Schoppmann et al., 2003), thyroid cancers
(Kebebew et al., 2000), endometrial cancers (Takai et al.,
2001), ovarian cancers (Schindl et al., 2003), cervical cancers
(Schindl et al., 2001), squamous cell carcinomas of the esopha-
gus (Hu et al., 2001) and nasopharynx (Wang et al., 2002), and
melanomas (Polsky et al., 2001). Id2 has been found to be
specifically upregulated in Ewing sarcomas, and the Id2 pro-
moter has been shown to be a transcriptional target of EWS-ets
fusion proteins (Fukuma et al., 2003; Nishimori et al., 2002). Id2
was also shown to be a downstream effector of myc proteins
and was felt to be the major effector of N-myc in early studies of
neuroblastomas (Lasorella et al., 2000, 2002); however, recent
studies have reviewed the role of Id2 in the genesis of neuro-
blastomas and its utility as a prognostic marker in large-scale
studies. These more recent large-scale data strongly suggest
that Id2 is not a critical effector of N-myc in neuroblastomas and
therefore not likely to be a useful prognostic marker in this dis-
ease (Vandesompele et al., 2003; Wang et al., 2003). Id1, Id2,
and Id3 are all upregulated in pancreatic cancers (Maruyama et
al., 1999), colorectal cancers (Wilson et al., 2001), astrocytic
tumors (Vandeputte et al., 2002), and squamous cell carcino-
mas of the head and neck (Langlands et al., 2000), and all four
Id genes are upregulated in testicular seminomas (Sablitzky et
al., 1998), further supporting the notion of Id genes as cellular
protooncogenes. In general, in situ evaluation of Id expression
in human tumors has revealed a correlation between tumor
invasiveness/aggressiveness/progression and Id expression
(Table 2). While both in situ hybridization techniques and
immunohistochemical techniques have been used to assess Id
gene expression in primary human tissue specimens (reviewed
in Lasorella et al., 2001), we have only had success using in situ
hybridization techniques for confirming Id1 expression in tissue
specimens. Of note, the commercially available antibody most
widely used for Id1 immunohistochemical techniques has not
been shown to be specific for Id1 in immunohistochemical stud-
ies published to date, and has been seen to have crossreactive
bands on Western analysis and crossreactive staining in Id1
null mice (R.M.A. and H.A.S., unpublished results). Monoclonal
antibodies against Id1 have recently been developed (Schaefer
et al., 2001), and are currently being tested for specificity in Id1
null mouse models.
While the data in primary human tumors is suggestive of a
link between Id gene expression and tumor development, few
studies to date have confirmed this link. The most convincing
link of Id genes to tumor development comes from transgenic
mouse model systems in which Id gene expression was target-
ed to particular tissue types. In these studies, Id1 (Kim et al.,
1999) and Id2 (Morrow et al., 1999) expression targeted to thy-
mocytes demonstrated aberrant T cell development, massive
apoptosis in targeted cells, and subsequent development of T
cell lymphomas, while targeted expression of Id1 to B-lympho-
cytes again resulted in aberrant B cell development, massive
apoptosis, and subsequent development of B cell lymphomas
(Sun, 1994). Targeted expression of Id1 to intestinal epithelia
resulted in the development of adenomas in a subset of these
animals (Wice and Gordon, 1998). Since E2A null mice also
develop T cell lymphomas in a fashion analogous to Id trans-
genic mice (Bain et al., 1997;Yan et al., 1997), it is likely that the
Id effects in thymocytes are mediated through inhibition of the
endogenous functions of E-proteins in T cell development.
While the data in the transgenic mouse model systems
described above is supportive of a role for Id genes in tumor-
igenesis, it must be considered that the complex functions of Id
genes in inducing apoptosis and promoting cell growth are like-
ly to influence the phenotypes of the particular targeted cells.
Overall, these transgenic mouse models demonstrate that Id
genes can induce malignant disease in vivo; however, whether
they do induce these types of lesions in human cancers
remains to be determined.
Id proteins and angiogenesis
Recent work has demonstrated the importance of Id gene
expression in regulating exogenous tumor cell growth and
metastasis (Lyden et al., 1999). Since mice lacking both Id1 and
Id3 genes are embryonic lethal at day E13.5 and possess
defects in angiogenesis, a series of experiments were carried
out in mice lacking one to three Id1 and/or Id3 alleles to deter-
mine if such animals could support tumor angiogenesis.
Surprisingly, mice lacking single or multiple Id1 and/or Id3 alleles
were unable to support growth of tumor explants. Specifically,
mice lacking even a single Id1 allele did not form tumors with
B6RV2 lymphoma cell explants, and were unable to support
metastases of Id1 null breast cancers. Additionally, Id1 +/− ani-
mals implanted with Lewis lung carcinoma cells survived twice
as long as wild-type animals and had significantly fewer metas-
tases. Since tumors that were either +/+ (B6RV2 and LLC) or −/−
(B-CA) for Id1 were significantly perturbed in their ability to grow
or metastasize in Id1 +/− animals and questions of immune toler-
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ance of the tumor explants were ruled out, it was evident that the
host itself was unable to support vascularization of the tumors.
While these investigators did note the striking phenotypic simi-
larity of Id1/Id3 double null embryos to αv-integrin null embryos
(Bader et al., 1998), their analyses revealed no alteration of Id
expression in αv-integrin null mice or vice versa. Furthermore,
expression of matrix metalloprotease 2 (MMP2), a target of αvβ3
integrins on endothelial cells, was also unaffected in the aberrant
ganglionic vasculature in Id1/Id3 null animals, suggesting other
downstream targets of Id1 and Id3 as being important regulators
of angiogenesis in that system. Recent data has identified
thrombospondin-1 as being a major mediator of Id1 effects on
angiogenesis, and the significance of this finding with respect to
tumor growth in Id null mice is currently under investigation
(Volpert et al., 2002). Other downstream effectors of Id1 were
identified in the above studies, and we await clarification of their
contribution to Id effects on tumor angiogenesis (Figure 3).
Conclusions
Id proteins have been demonstrated to play a role in a variety of
biologic processes that have been implicated in regulating
tumorigenesis; however, no putative alterations of Id genes
have been identified in primary human tumors to date to certify
Ids as true cellular protooncogenes. The most recent data on Id
gene expression in primary human malignancies has received
much attention, since these data suggest that Id proteins, or
their downstream effectors, may be bona fide targets for treat-
ment of a variety of human malignancies. While the associa-
tions between Id gene expression and cancer have been
mounting, few experiments have proven, unequivocally, the link
between Id expression and malignant progression. The data
published to date in human tumors have been mostly observa-
tional and may be called into question given the variable reliabil-
ity of reagents used in some studies. It is expected that, over the
next few years, the field will move from mostly observational dis-
coveries to functional studies of Id genes in tumors using the
latest techniques for gene silencing in cell culture and in vivo
model systems. In addition, studies using improved diagnostic
tests and protein detection methods for Id gene products will
allow for a clearer understanding of the true nature of Id gene
expression in human cancers, their functions in malignant con-
version and tumor progression, and their utility as molecular tar-
gets for cancer therapeutics.
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